$22.60
0.040.18%
At Close: -
$22.60
00.00%
After Hours: Jul 19, 5:07 PM EDT
15 minutes delayed
Comments
Loading...
Exelixis
EXELNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Exelixis (NASDAQ:EXEL) Stock, Analyst Ratings, Price Targets, Forecasts
Exelixis Inc has a consensus price target of $27.68 based on the ratings of 25 analysts. The high is $42 issued by HC Wainwright & Co. on February 18, 2022. The low is $18 issued by SVB Leerink on August 8, 2023. The 3 most-recent analyst ratings were released by Stephens & Co., HC Wainwright & Co., and TD Cowen on May 14, 2024, May 3, 2024, and May 1, 2024, respectively. With an average price target of $26 between Stephens & Co., HC Wainwright & Co., and TD Cowen, there's an implied 15.04% upside for Exelixis Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stephens & Co.
HC Wainwright & Co.
TD Cowen
Barclays
JMP Securities
1calculated from analyst ratings
Analyst Ratings for Exelixis
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/14/2024 | Buy Now | 1.77% | Stephens & Co. | Sudan Loganathan | → $23 | Initiates | → Equal-Weight | Get Alert |
| 05/03/2024 | Buy Now | 23.89% | HC Wainwright & Co. | Robert Burns | → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | Buy Now | 19.47% | TD Cowen | Yaron Werber | $25 → $27 | Maintains | Buy | Get Alert |
| 04/11/2024 | Buy Now | 10.62% | Barclays | Peter Lawson | $25 → $25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/10/2024 | Buy Now | 19.47% | JMP Securities | Silvan Tuerkcan | → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/07/2024 | Buy Now | 23.89% | RBC Capital | Gregory Renza | $26 → $28 | Maintains | Outperform | Get Alert |
| 02/02/2024 | Buy Now | 10.62% | Stifel | Stephen Willey | $23 → $25 | Maintains | Hold | Get Alert |
| 01/30/2024 | Buy Now | 10.62% | Barclays | Peter Lawson | $24 → $25 | Maintains | Overweight | Get Alert |
| 12/19/2023 | Buy Now | 19.47% | BTIG | Kaveri Pohlman | → $27 | Initiates | → Buy | Get Alert |
| 12/15/2023 | Buy Now | 37.17% | Citigroup | David Lebowitz | → $31 | Initiates | → Buy | Get Alert |
| 12/14/2023 | Buy Now | 19.47% | JMP Securities | Silvan Tuerkcan | → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/13/2023 | Buy Now | 15.04% | RBC Capital | Gregory Renza | → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2023 | Buy Now | 19.47% | JMP Securities | Silvan Tuerkcan | → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/02/2023 | Buy Now | 1.77% | Morgan Stanley | Jefferson Harralson | $22 → $23 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | Buy Now | 32.74% | Guggenheim | Michael Schmidt | → $30 | Reiterates | Buy → Buy | Get Alert |
| 09/26/2023 | Buy Now | 23.89% | HC Wainwright & Co. | Robert Burns | → $28 | Initiates | → Buy | Get Alert |
| 09/25/2023 | Buy Now | 32.74% | Guggenheim | Michael Schmidt | $27 → $30 | Maintains | Buy | Get Alert |
| 09/13/2023 | Buy Now | 1.77% | Stifel | Stephen Willey | → $23 | Reiterates | Hold → Hold | Get Alert |
| 09/13/2023 | Buy Now | 41.59% | Truist Securities | Asthika Goonewardene | → $32 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2023 | Buy Now | 28.32% | Oppenheimer | Jay Olson | $25 → $29 | Maintains | Outperform | Get Alert |
| 08/22/2023 | Buy Now | 19.47% | JMP Securities | Silvan Tuerkcan | $24 → $27 | Maintains | Outperform | Get Alert |
| 08/08/2023 | Buy Now | -20.35% | SVB Leerink | Christopher Liu | → $18 | Initiates | → Market Perform | Get Alert |
| 08/03/2023 | Buy Now | 6.19% | Barclays | Peter Lawson | $25 → $24 | Maintains | Overweight | Get Alert |
| 08/02/2023 | Buy Now | 1.77% | Stifel | Stephen Willey | $21 → $23 | Maintains | Hold | Get Alert |
| 08/02/2023 | Buy Now | -2.65% | Morgan Stanley | Jefferson Harralson | $21 → $22 | Maintains | Equal-Weight | Get Alert |
| 08/02/2023 | Buy Now | 6.19% | JMP Securities | Silvan Tuerkcan | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/31/2023 | Buy Now | 10.62% | Oppenheimer | Jay Olson | → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 07/19/2023 | Buy Now | 6.19% | JMP Securities | Silvan Tuerkcan | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/11/2023 | Buy Now | -7.08% | Morgan Stanley | Jefferson Harralson | → $21 | Reinstates | → Equal-Weight | Get Alert |
| 05/10/2023 | Buy Now | 6.19% | JMP Securities | Silvan Tuerkcan | → $24 | Reiterates | → Market Outperform | Get Alert |
| 05/10/2023 | Buy Now | 23.89% | Piper Sandler | Joseph Catanzaro | → $28 | Assumes | → Overweight | Get Alert |
| 04/28/2023 | Buy Now | 6.19% | EF Hutton | Michael King | → $24 | Reiterates | → Buy | Get Alert |
| 04/12/2023 | Buy Now | -7.08% | Morgan Stanley | Jefferson Harralson | $22 → $21 | Maintains | Equal-Weight | Get Alert |
| 03/20/2023 | Buy Now | 6.19% | EF Hutton | Michael King | → $24 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 1.77% | Wells Fargo | Derek Archila | → $23 | Initiates | → Overweight | Get Alert |
| 03/03/2023 | Buy Now | 6.19% | EF Hutton | Michael King | → $24 | Reiterates | → Buy | Get Alert |
| 02/14/2023 | Buy Now | 6.19% | EF Hutton | Michael King | → $24 | Maintains | Buy | Get Alert |
| 02/08/2023 | Buy Now | 41.59% | Piper Sandler | Alexander Goldfarb | → $32 | Maintains | Overweight | Get Alert |
| 02/08/2023 | Buy Now | 6.19% | EF Hutton | Michael King | → $24 | Reiterates | → Buy | Get Alert |
| 01/26/2023 | Buy Now | 28.32% | Credit Suisse | Tiago Fauth | → $29 | Initiates | → Outperform | Get Alert |
| 01/19/2023 | Buy Now | 6.19% | JMP Securities | Silvan Tuerkcan | $25 → $24 | Maintains | Market Outperform | Get Alert |
| 01/11/2023 | Buy Now | 6.19% | EF Hutton | Michael King | $28 → $24 | Maintains | Buy | Get Alert |
| 12/09/2022 | Buy Now | 10.62% | JMP Securities | Silvan Tuerkcan | $26 → $25 | Maintains | Market Outperform | Get Alert |
| 11/02/2022 | Buy Now | 28.32% | RBC Capital | Gregory Renza | $31 → $29 | Maintains | Outperform | Get Alert |
| 11/02/2022 | Buy Now | -2.65% | Morgan Stanley | Jeffrey Hung | $23 → $22 | Maintains | Equal-Weight | Get Alert |
| 11/01/2022 | Buy Now | 23.89% | EF Hutton | Michael King | → $28 | Initiates | → Buy | Get Alert |
| 10/18/2022 | Buy Now | 15.04% | JMP Securities | Silvan Tuerkcan | → $26 | Initiates | → Market Outperform | Get Alert |
| 07/26/2022 | Buy Now | 41.59% | Piper Sandler | Do Kim | $30 → $32 | Maintains | Overweight | Get Alert |
| 07/15/2022 | Buy Now | 1.77% | Morgan Stanley | Jeffrey Hung | $22 → $23 | Maintains | Equal-Weight | Get Alert |
| 06/24/2022 | Buy Now | 23.89% | BMO Capital | Etzer Darout | → $28 | Initiates | → Outperform | Get Alert |
| 02/18/2022 | Buy Now | 85.84% | HC Wainwright & Co. | Michael King | $52 → $42 | Maintains | Buy | Get Alert |
| 11/03/2021 | Buy Now | 37.17% | RBC Capital | Kennen MacKay | — | Maintains | Outperform | Get Alert |
| 11/03/2021 | Buy Now | 130.09% | HC Wainwright & Co. | Michael King | — | Maintains | Buy | Get Alert |
| 11/02/2021 | Buy Now | 28.32% | Oppenheimer | Jay Olson | — | Maintains | Outperform | Get Alert |
| 10/07/2021 | Buy Now | 23.89% | Jefferies | Akash Tewari | — | Initiates | → Buy | Get Alert |
| 09/20/2021 | Buy Now | 59.29% | Truist Securities | Asthika Goonewardene | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Exelixis (EXEL) stock?
The latest price target for Exelixis (NASDAQ:EXEL) was reported by Stephens & Co. on May 14, 2024. The analyst firm set a price target for $23.00 expecting EXEL to rise to within 12 months (a possible 1.77% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Exelixis (EXEL)?
The latest analyst rating for Exelixis (NASDAQ:EXEL) was provided by Stephens & Co., and Exelixis initiated their equal-weight rating.
When was the last upgrade for Exelixis (EXEL)?
There is no last upgrade for Exelixis
When was the last downgrade for Exelixis (EXEL)?
The last downgrade for Exelixis Inc happened on April 11, 2024 when Barclays changed their price target from $25 to $25 for Exelixis Inc.
When is the next analyst rating going to be posted or updated for Exelixis (EXEL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exelixis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exelixis was filed on May 14, 2024 so you should expect the next rating to be made available sometime around May 14, 2025.
Is the Analyst Rating Exelixis (EXEL) correct?
While ratings are subjective and will change, the latest Exelixis (EXEL) rating was a initiated with a price target of $0.00 to $23.00. The current price Exelixis (EXEL) is trading at is $22.60, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.